Biotech Co.* (Country; Symbol)

Pharma Co. (Country)

Product

Terms/Details (Date)


Acorda Therapeutics Inc.*

Rxpedite (joint venture between inChord Communications and Cardinal Health Inc.)

Fampridine-SR

Marketing agreement related to possible launch of sustained-release product; Rxpedite will manage all communications efforts (9/28)

Althea Technologies Inc.*

Baxter Healthcare Corp.

Co-promotion agreement for Althea's plasmid DNA manufacturing services and both firms' contract fill and finish services

Althea will provide small batch services to customers through Phase III, and Baxter will service commercialization efforts (9/7)

BioMarin Pharmaceuticals Inc. (BMRN)

Merck Eprova AG (subsidiary of Merck KGaA; Germany)

Manufacturing and supply agreement for BioMarin's Phenoptin (6R-BH4), a drug nearing clinical trials for phenylketonuria

BioMarin and Merck will share process development and manufacturing costs; Merck will supply product for clinical trials and would get royalties on commercial sales (11/20)

Cellectis SA* (France)

Fermentas UAB (Lithuania)

The endonuclease I-SceI

Cellectis granted Fermentas a nonexclusive worldwide license for manufacturing and selling the endonuclease; terms were not disclosed (11/18)

FeRx Inc.*

Laureate Pharma LLP

MTC-DOX

Laureate will provide fill and finishing services under the manufacturing agreement, terms of which were not disclosed (10/14)

Codexis Inc. (subsidiary of Maxygen Inc.; MAXY)

Sandoz Inc. (unit of Novartis AG; Switzerland)

Sandoz compound

Collaboration to develop an improved process for manufacturing a Sandoz compound; Codex will get up-front and R&D funding, and potential milestone and royalty payments (10/27)

EraGen Biosciences Inc. Inc.*

Itochu Corp. and CTC Laboratory Systems Corp. (both of Japan)

EraGen's phylogenomics product, Master Catalog

The two firms will exclusively distribute the product in Japan; terms were not disclosed (11/17)

Labopharm Inc. (Canada; TSE:DDS)

CSC Pharmaceuticals Handels GmbH (Austria)

Once-daily version of the analgesic tramadol

Labopharm's European subsidiary granted GCS the right to market and sell the product in 14 Eastern European countries; Labopharm will supply product and earn a share of any revenues (11/6)

Nabi Biopharmaceuticals (NABI)

Cambrex Corp.

Manufacturing agreement for StaphVax vaccine

Nabi granted Cambrex a 10-year renewable contract to manufacture the vaccine (10/9)

Ortec International Inc. (OTT BB:ORTN)

Teva Pharmaceutical Industries Ltd. (Israel)

OrCel tissue-engineered product

Teva obtained a 10-year license to sell OrCel in Israel for wound healing and other dermatological applications; terms were not disclosed (10/23)

Viragen Inc. (AMEX:VRA)

Pentafarma SA (Chile; subsidiary of Fresenius Medical Care)

Distribution agreement for Viragen's Multiferon

Pentafarma gained exclusive rights to sell the product in Chile; terms were not disclosed (11/17)

ZymoGenetics Inc. (ZGEN)

Abbot Laboratories

Recombinant human thrombin

Abbott will be responsible for production of product for late-stage clinical studies and commercial sales; terms were not disclosed (10/2)


Notes:

# The information in the chart does not cover agricultural agreements or those between biotech companies.

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; TSE: Toronto Stock Exchange.

No Comments